Company Filing History:
1 out of 832,880 Years Active: 2012
Title: Jean-Guy Gilles: Innovator in Hemophilia Treatment
Introduction
Jean-Guy Gilles is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of medicine, particularly in the treatment of hemophilia A. His innovative work has led to the development of a unique patent that addresses critical challenges in this area.
Latest Patents
Jean-Guy Gilles holds a patent for "Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the C1 domain of Factor VIII." This invention relates to a monoclonal anti-idiotypic antibody that targets a Factor VIII inhibitor antibody binding to the C1 domain of Factor VIII. The patent also includes a cell line that produces this monoclonal anti-idiotypic antibody, which can be used as a medicament for treating hemophilia A.
Career Highlights
Throughout his career, Jean-Guy Gilles has focused on advancing medical treatments through innovative research. His work has been instrumental in developing therapies that improve the quality of life for individuals suffering from hemophilia A. His dedication to research and innovation has positioned him as a key figure in the medical community.
Collaborations
Jean-Guy Gilles has collaborated with esteemed colleagues, including Marc G Jacquemin and Jean-Marie Saint-Remy. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical solutions.
Conclusion
Jean-Guy Gilles is a prominent inventor whose work in the field of hemophilia treatment has made a lasting impact. His innovative patent and collaborations with other experts highlight his commitment to advancing medical science.